Cargando…
Antiphospholipid Antibodies Increase the Risk of Fetal Growth Restriction: A Systematic Meta-Analysis
OBJECTIVE: Antiphospholipid syndrome (APS) is a chronic autoimmune disease with a high prevalence in females. Published data have identified pregnant women with APS may suffer from recurrent miscarriage, fetal death. However, the association between antiphospholipid antibody (aPL) and fetal growth r...
Autores principales: | Xu, Jinfeng, Chen, Daijuan, Tian, Yuan, Wang, Xiaodong, Peng, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159204/ https://www.ncbi.nlm.nih.gov/pubmed/35685559 http://dx.doi.org/10.1155/2022/4308470 |
Ejemplares similares
-
Comparison of treatments for the prevention of fetal growth restriction in obstetric antiphospholipid syndrome: a systematic review and network meta-analysis
por: Urban, Maria Letizia, et al.
Publicado: (2021) -
Effect of prophylactic balloon occlusion of internal iliac artery in pregnancies complicated by placenta previa and accreta
por: Chen, Daijuan, et al.
Publicado: (2021) -
Recurrent Fetal Loss and Antiphospholipid Antibodies: Clinical and Therapeutic Aspects
por: Blétry, O., et al.
Publicado: (1997) -
Antiphospholipid Antibody and Risk of Retinal Vein Occlusion: A Systematic Review and Meta-Analysis
por: Zhu, Wei, et al.
Publicado: (2015) -
Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review
por: Taha, Muhanad, et al.
Publicado: (2021)